Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Hoe eerder, hoe beter? Debat over behandelen van artralgie
mrt 2020 | Reumatoïde artritis